MindMaze
MindMaze develops innovative neurotherapeutic combinations and a treatment ecosystem encompassing behavior, software, devices, and data to transform care for debilitating neurological diseases.
Classification
Profile
Funding
Funding details not yet available.
A precision neurotherapeutic treatment ecosystem combining behavior, software, devices, and data to redefine brain health and recovery.
Patients with debilitating neurological diseases and healthcare providers seeking advanced neurotherapeutic interventions.
Digital therapeutic solutions for neurological diseases, likely involving commercial sales of clinical development pipelines.
Global commercial growth plans supported by strategic funding rounds to accelerate market expansion.
Investors providing financing for global growth and R&D; likely clinical partners for digital therapeutic validation.
R&D for developing neurotherapeutic combinations, software, and devices within a proprietary treatment ecosystem.
Proprietary technology platform, neurotherapeutic data, and expertise in combining behavior, software, and devices.
Developing innovative neurotherapeutic combinations and managing a treatment ecosystem for brain health and recovery.
Commercial growth focused, leveraging funding to expand reach for neurological treatment solutions.
Leaders in neurotherapeutic combinations; differentiates by integrating behavior, software, devices, and data for precision care.
Need for effective care for debilitating neurological diseases and the complexity of managing brain health recovery.
- Expand payer-centric value propositions - Develop bundled “outcome-as-a-service” contracts that tie reimbursement to specific functional
- Map high-value payer segments (e.g., Medicare Advantage, large employer health plans) and pilot outcome-based contracts within 6 months
- Clinical validation - Multiple peer-reviewed studies (e.g., PubMed 2025 high-dose gamified rehab trial) demonstrate statistically signifi
No investors recorded yet.